Leading science, pioneering therapies

CRM Publications

Found 19 results
Filters: Keyword is Schwann Cells  [Clear All Filters]
2014
Lavasani M, Thompson SD, Pollett JB, Usas A, Lu A, Stolz DB, Clark KA, Sun B, Péault B, Huard J.  2014.  Human muscle-derived stem/progenitor cells promote functional murine peripheral nerve regeneration.J Clin Invest. 124(4):1745-56.
2013
Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A.  2013.  Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection.Cell. 152(1-2):51-67.
2012
Hampton DW, Innes N, Merkler D, Zhao C, Franklin RJM, Chandran S.  2012.  Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency.Am J Pathol. 180(5):1897-905.
Wu LMan N, Williams AC, Delaney A, Sherman DL, Brophy PJ.  2012.  Increasing internodal distance in myelinated nerves accelerates nerve conduction to a flat maximum.Curr Biol. 22(20):1957-61.
2006
Tapinos N, Ohnishi M, Rambukkana A.  2006.  ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli.Nat Med. 12(8):961-6.
Im JS, Tapinos N, Chae G-T, Illarionov PA, Besra GS, DeVries GH, Modlin RL, Sieling PA, Rambukkana A, Porcelli SA.  2006.  Expression of CD1d molecules by human schwann cells and potential interactions with immunoregulatory invariant NK T cells.J Immunol. 177(8):5226-35.
2004
Rambukkana A.  2004.  Mycobacterium leprae-induced demyelination: a model for early nerve degeneration.Curr Opin Immunol. 16(4):511-8.
2003
Oliveira RB, Ochoa MT, Sieling PA, Rea TH, Rambukkana A, Sarno EN, Modlin RL.  2003.  Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy.Infect Immun. 71(3):1427-33.
Rambukkana A, Kunz S, Min J, Campbell KP, Oldstone MBA.  2003.  Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.Proc Natl Acad Sci U S A. 100(26):16071-6.
2002
Rambukkana A, Zanazzi G, Tapinos N, Salzer JL.  2002.  Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.Science. 296(5569):927-31.
2001
Rambukkana A.  2001.  Molecular basis for the peripheral nerve predilection of Mycobacterium leprae.Curr Opin Microbiol. 4(1):21-7.
2000
Rambukkana A.  2000.  How does Mycobacterium leprae target the peripheral nervous system?Trends Microbiol. 8(1):23-8.
Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A et al..  2000.  Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice.Neuron. 26(2):523-31.
Ng V, Zanazzi G, Timpl R, Talts JF, Salzer JL, Brennan PJ, Rambukkana A.  2000.  Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae.Cell. 103(3):511-24.
1999
Shimoji Y, Ng V, Matsumura K, Fischetti VA, Rambukkana A.  1999.  A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion.Proc Natl Acad Sci U S A. 96(17):9857-62.
1998
Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA.  1998.  Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae.Science. 282(5396):2076-9.
1997
Rambukkana A, Salzer JL, Yurchenco PD, Tuomanen EI.  1997.  Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-alpha2 chain.Cell. 88(6):811-21.
Livesey FJ, O'Brien JA, Li M, Smith AG, Murphy LJ, Hunt SP.  1997.  A Schwann cell mitogen accompanying regeneration of motor neurons.Nature. 390(6660):614-8.